MD, FRCPC
Director, ALS Centre of Excellence for Research and Patient Care
Executive Director, Clinical Research Unit at The Neuro
Associate Professor, McGill University
Montreal, QC
MD, PhD, FRCPC, CSCN (EMG)
Division Head of Neurology, Trillium Health Partners
Clinical Assistant Professor, University of Toronto
Toronto, ON
MD, FRCPC, CSCN (EMG)
Maritime Neurology
Halifax, NS
We want to help you identify patients who present multiple red flags for ALS, so that they can receive expedited follow-ups, diagnoses, and ultimately treatment for those who need it.
Early diagnosis and treatment of ALS can improve outcomes, but the disease can be difficult to diagnose in its early stages. The more time passes, the more patients miss out on disease-management opportunities that can enhance their quality of life.
By joining this initiative...
A clinical algorithm would be applied to your de-identified EMR data by Ensho Health, our trusted partner and expert developer of digital diagnostic solutions. Ensho’s algorithm has been proven to identify patients with an elevated risk of ALS and can highlight which ones require further follow-up. By joining this initiative, you can intervene in patients’ journeys sooner – a worthwhile prospect indeed.
This quality improvement initiative has been reviewed and approved by an independent ethics review board.
Ensho Health is a Canadian digital healthcare services company that provides on-demand analysis of health information to match patients with clinical trials, build better real-world evidence and accelerate rare disease diagnosis and treatment.
This initiative is supported by Mitsubishi Tanabe Pharma.
EOCI is the organizing committee and medical education partner for this initiative.
